David Reardon, Md
Clinical trials sponsored by David Reardon, Md, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New hope for recurrent brain cancer? early trial of CUE-102 begins Results expected Jan 2027 (estimated)
-
Brain cancer hope: new drugs tested in major trial
Disease control Recruiting nowThis Phase 2 trial is testing several experimental drugs, alone or in combination, for people with newly diagnosed glioblastoma, an aggressive brain cancer. About 460 participants will receive one of the study drugs or standard therapy. The main goal is to see if these new treatm…
Phase 2 • Sponsor: David Reardon, MD • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for recurrent brain cancer? early trial of CUE-102 begins
Disease control Recruiting nowThis early-phase trial tests an experimental drug called CUE-102 in 18 adults with recurrent glioblastoma, a type of brain cancer that has come back. The drug is a fusion protein designed to help the immune system attack cancer cells. The main goal is to find a safe dose and chec…
Phase 1 • Sponsor: David Reardon, MD • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC